Ä«Å×°í¸®
|
Cytokines & Growth Factor
|
CAT.NO
|
LGP-12-078
|
PRODUCT
|
IFN-¥ë3/IL-28B, Mouse (Murine Interferon-lambda3/Interleukin-28B)
|
SIZE
|
20ug, 100ug, 500ug
|
PRICE
|
KRW 285,000, 880,000, 2,569,000
|
Technical Parameters
Accession |
Q8CGK6 |
GeneID |
338374 |
Source |
Escherichia coli. |
Molecular Weight |
Approximately 19.6 kDa, a single non-glycosylated polypeptide chain containing 174 amino acids. |
Quantity |
20µg/100µg/500µg |
AA Sequence |
DPVPRATRLP VEAKDCHIAQ FKSLSPKELQ AFKKAKGAIE KRLLEKDMRC SSHLISRAWD LKQLQVQERP KALQAEVALT LKVWENINDS ALTTILGQPL HTLSHIHSQL QTCTQLQATA EPKPPSRRLS RWLHRLQEAQ SKETPGCLED SVTSNLFQLL LRDLKCVASG DQCV |
Purity |
> 98 % by SDS-PAGE and HPLC analyses. |
Biological Activity |
Fully biologically active when compared to standard. The ED50 as determined by an anti-viral assay using human HepG2 cells infected with encephalomyocarditis is less than 30 ng/ml, corresponding to a specific activity of > 3.3 ¡¿ 104 IU/mg. |
Physical Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation |
Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4. |
Endotoxin |
Less than 1 EU/µg of rMuIFN-¥ë3/IL-28B as determined by LAL method. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ¡Â -20 ¡ÆC. Further dilutions should be made in appropriate buffered solutions. |
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 ¡ÆC as supplied. - 1 month, 2 to 8 ¡ÆC under sterile conditions after reconstitution. - 3 months, -20 to -70 ¡ÆC under sterile conditions after reconstitution. |
Usage |
This material is offered by Korea Lugen Sci for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. |
SDS-PAGE |
|
|
÷ºÎÆÄÀÏ
|
|
|
|
|